Comprehensive analysis of UTI-Small Cap Fund - Direct (IDCW) (41778) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
UTI Asset Management Company Ltd
The objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of small cap companies. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Weak Returns
High Risk
Low Expense Ratio
Equity Focused
Established Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Outperformance vs benchmark
Historical performance consistency
Market exposure level
Fund management costs
Recent performance momentum
Fund manager experience
Assets under management
Risk-adjusted returns
This fund has underperformed its benchmark by 1.96% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Industry | % Assets |
|---|---|---|
| Net CA & Others | Debt Others | 5.30% |
| Multi Commodity Exchange of India Ltd | Financial Services | 3.26% |
| City Union Bank Ltd | Banks | 2.35% |
| Karur Vysya Bank Ltd | Banks | 2.29% |
| Navin Fluorine International Ltd | Chemicals | 2.12% |
| Techno Electric & Engineering Company Ltd | Infrastructure Developers & Operators | 2.09% |
| Aster DM Healthcare Ltd | Healthcare | 2.05% |
| ERIS Lifesciences Ltd | Pharmaceuticals | 2.02% |
| Affle 3i Ltd | IT - Software | 1.93% |
| J K Cements Ltd | Cement | 1.83% |
Compare against Small Cap Fund category average
This comparison shows how the fund performs relative to the Small Cap Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Small Cap Fund category
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| Kotak Small Cap Fund - Direct (G) | ₹306.49 | 20.35% | -5.69% | 17.20% |
| Sundaram Small Cap Fund - Direct (G) | ₹283.60 | 24.41% | -2.76% | 21.09% |
| Quant Small Cap Fund - Direct (G) | ₹273.44 | 18.46% | -9.78% | 25.25% |
| Kotak Small Cap Fund (G) | ₹260.83 | 19.68% | -6.75% | 15.80% |
| Sundaram Small Cap Fund (G) | ₹255.83 | 23.74% | -3.80% | 19.76% |
| Quant Small Cap Fund - (G) | ₹251.40 | 17.91% | -10.62% | 23.94% |
| DSP Small Cap Fund - Direct (G) | ₹215.77 | 26.23% | -1.41% | 21.46% |
| Quant Small Cap Fund - Direct (IDCW) | ₹213.75 | 18.45% | -9.78% | 25.26% |
| Quant Small Cap Fund - (IDCW) | ₹199.93 | 17.91% | -10.62% | 23.97% |
| SBI Small Cap Fund - Direct (G) | ₹197.69 | 18.67% | -5.52% | 16.12% |
A seasoned investment professional with over 5 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.